The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives RFK Jr. promotes peptides. Now the FDA weighs easing limits on the unproven chemicals Q&A: Should you trust trending peptide injections? Early evidence suggests BPC 157 repairs tissue rather than just dulling symptoms. To read more, tap the link in bio.